Rebecca Arend MD
Gynecologic Oncology
Academic Appointment: Associate Professor - UAB Women & Infants Center
Join to View Full Profile
619 19th St SBirmingham, AL 35249
Phone+1 205-934-4011
Fax+1 205-297-9411
Dr. Arend is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Rebecca Arend is an obstetrician/gynecologist in Birmingham, AL and is affiliated with UAB Hospital. She received her medical degree from Albert Einstein College of Medicine and has been in practice 9 years. She specializes in gynecologic oncology and is experienced in gynecologic oncology.
Education & Training
University of Alabama Medical CenterFellowship, Gynecologic Oncology, 2015
New York Presbyterian Hospital (Columbia Campus)Residency, Obstetrics and Gynecology, 2008 - 2012
Albert Einstein College of MedicineClass of 2008
Certifications & Licensure
AL State Medical License 2012 - 2025
NY State Medical License 2011 - 2012
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer Start of enrollment: 2017 Nov 15
- A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma Start of enrollment: 2018 Mar 05
- Trial of M4344 and Niraparib in Patients With Poly (ADP-ribose) Polymerase (PARP) Resistant Recurrent Ovarian Cancer Start of enrollment: 2023 May 01
- Join now to see all
Publications & Presentations
PubMed
- Incorporation of triapine (T) to cisplatin chemoradiation (CRT) for locally advanced cervical and vaginal cancer: Results from NRG-GY006, a phase III randomized trial.Charles A Leath 3rd, Wei Deng, Loren K Mell, Debra L Richardson, Joan L Walker
Gynecologic Oncology. 2025-03-17 - Targeting Mediator Kinase Cyclin-Dependent Kinases 8/19 Potentiates Chemotherapeutic Responses, Reverses Tumor Growth, and Prolongs Survival from Ovarian Clear Cell Ca...Wade C Barton, Asha Kumari, Zachary T Mack, Gary P Schools, Liz Macias Quintero
Cancers. 2025-03-10 - Platinum-free interval and response to platinum retreatment or lenvatinib/pembrolizumab in patients with recurrent endometrial cancer: A real-world endometrial cancer ...Paulina J Haight, Marilyn Sanchez, Samantha M Thomas, Carson Smitherman, Casey Cosgrove
Gynecologic Oncology. 2025-02-21
Press Mentions
UAB eMedicine Launches Online Second Opinion ServiceMarch 31st, 2025- Immunotherapy’s Role in Treating Endometrial Cancer Expected to GrowApril 12th, 2023
- Two “Homerun” Trials Expected to Change Standard for Advanced, Recurrent Endometrial CancerMarch 28th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
